Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Clin Transplant. 2013 Jan 27;27(3):348–358. doi: 10.1111/ctr.12074

Table 4.

Multivariate model results with top 15 SNPs (ranked by p-value) associated with time to CGD, stratified by transplant center.(n=979) All variant data from dbSNP Build 132

SNP Genec Variant HRa 95% CI P Value Minor allele in AA MAF in AA Minor allele in non-AA MAF in non-AA
rs7886938 FMO6d Coding-synonb 1.60 1.26–2.04 1.47E-04 A 0.19 A 0.16
rs7889839 FMO6d Missenseb 1.60 1.25–2.04 1.58E-04 G 0.19 G 0.16
rs2272797 FMO6d Missenseb 1.57 1.23–2.01 3.15E-04 A 0.17 A 0.16
rs909530 FMO3d Coding-synon 1.50 1.20–1.87 3.52E-04 T 0.48 T 0.25
rs3769148 ZAK Missense 0.68 0.54–0.85 5.61E-04 A 0.11 A 0.47
rs2369679 AK7 Missense 1.58 1.20–2.08 1.07E-03 C 0.03 C 0.17
rs2239360 FANCA Intron 1.42 1.15–1.76 1.22E-03 C 0.35 T 0.34
rs10916 CYP1B1 Untranslated-3 1.45 1.16–1.83 1.38E-03 G 0.3 G 0.21
rs2242480 CYP3A4 Intron 1.59 1.19–2.13 1.59E-03 C 0.29 T 0.11
rs916864 PON3 Intronb 0.62 0.46–0.84 1.78E-03 T 0.09 T 0.22
rs609636 CYP4F12 Missense 0.37 0.20–0.69 1.85E-03 T 0.07 T 0.06
rs609290 CYP4F12 Missense 0.37 0.20–0.69 1.89E-03 T 0.07 T 0.06
rs1639 PON2 Intron 0.63 0.47–0.85 2.13E-03 G 0.1 G 0.23
rs7190823 FANCA Missense 1.39 1.12–1.72 2.59E-03 T 0.32 C 0.42
rs12448860 FANCA Intron 1.37 1.11–1.69 3.17E-03 T 0.37 A 0.42

(Abbreviations: AA= African Americans, MAF= Minor Allele Frequency, synon=synonymous, untranslated-3= variant in the untranslated 3′ end of gene, HR= Hazard Ratio)

a

Analysis conducted using a Cox proportional hazards model stratified by transplant center and adjusted by recipient race. Hazard ratio and 95% CI of CGD for each risk allele. Model also adjusted for confounders such as donor age and recipient characteristics such as African-American race, smoking status, recipient-donor CMV status, and age.

b

UCSC predicted variant relative to gene track

c

There was linkage disequilibrium (LD) between the three SNPs in FMO6 namely rs7886938 and rs7886938 and rs7889839 with r2=1.0 in both non-AAs and greater than 0.88 in AA’s. The FMO3 SNP, namely rs909530 is not in LD with FMO6 SNPs in non-AAs and AAs, with r2 less than 0.8.

SNPs in FANCA, rs7190823 and rs12448860 are in LD in non-AA only with r2=0.98.

SNPs in PON2 and PON3 rs1639 and rs916864, respectively are in LD with r2= 0.84 in non-AAs and 0.90 in AAs.

SNPs in CYP4F12, rs609636 and rs609290 are in LD in r2= 1.0 in AA and non-AA.

d

SNPs statistically significant after accounting for an false-discovery rate of 20%.